In a setback to Cipla, the Delhi high court on Friday held that the Indian drug major was infringing Swiss pharmaceutical company Hoffman-La Roche’s patent in lung cancer drug erlotinib hydrochloride, sold under the name of Tarceva. A division bench of Justice Pradeep Nandrajog and Justice Mukta Gup...